Evidence map›Paper›PMID 22539578›Full record

ArticleNeurology2012

Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory.

S Barral, T Bird, A Goate, M R Farlow, R Diaz-Arrastia, D A Bennett, N Graff-Radford, B F Boeve, R A Sweet, Y Stern and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Neurology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Lack of association between bridging integrator 1 (Alzheimer's & dementia (New York, N. Y.) · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 20 institutions in 2 countries.

S BarralGertrude H. Sergievsky Center, The Taub Institute for Research on Alzheimer’s Disease and the Aging Brain and the Department ofNeurology, Columbia University College of Physicians and Surgeons, New York, NY, USA.
T Bird
A Goate
M R Farlow
R Diaz-Arrastia
D A Bennett
N Graff-Radford
B F Boeve
R A Sweet
Y Stern
R S Wilson
T Foroud
J Ott
R Mayeux
National Institute on Aging Late-Onset Alzheimer's Disease Genetics Study
University of Washington · USIcahn School of Medicine at Mount Sinai · USIndiana University · USRush University · USMassachusetts General Hospital · USMayo Clinic · USNorthwestern University · PHThe University of Texas Southwestern Medical Center · USUniversity of California, Los Angeles · USUniversity of Pittsburgh · USBoston University · USEmory University · USCalifornia University of Pennsylvania · USColumbia University · USDuke University · USJacksonville College · USUniversity of Kentucky · USUniversity of Southern California · USWinnMed · USIndiana University – Purdue University Indianapolis · US

Funding

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
Alzheimer's Disease Genetics ConsortiumU01AG032984 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2024
$60.4M
THERAPEUTIC EFFECTS OF INTRA-NASAL INSULIN DETEMIRP50AG005136 · NIA · UNIVERSITY OF WASHINGTON · PI JAYADEY, SUMAN · 1985 to 2019
$57.2M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 1985 to 2019
$52.1M
SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
Satellite Diagnostic and Treatment Clinic CoreP50AG008702 · NIA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI DE JAGER, PHILIP L · 1989 to 2019
$46.3M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
TREATMENT OF DEPRESSION IN ALZHEIMER'S DISEASEP50AG005133 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BECKER, JAMES T. · 1985 to 2019
$43.0M
THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIAP50AG005134 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 1985 to 2018
$42.1M
VASCULAR RISK AND COGNITIVE STATUS IN A LATINO POPULATIONP50AG005142 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ARANDA, MARIA P. · 1985 to 2019
$41.0M
VESICULAR LOCALIZATION AND FUNCTION OF PRESENILIN 1 FRAGMENTP50AG005138 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SCHIMMING, CORBETT · 1985 to 2019
$37.9M
Research Education ComponentP30AG010133 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SAYKIN, ANDREW J · 1991 to 2020
$37.3M
NHGRI NIH HHS HHSN268200782096CNIA NIH HHS P30 AG008017NIA NIH HHS P30 AG010124NIA NIH HHS P30AG010124NIA NIH HHS P30 AG010133NIA NIH HHS P30AG010133NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG012300NIA NIH HHS P30AG012300NIA NIH HHS P30 AG013846NIA NIH HHS P30AG013846NIA NIH HHS P30 AG013854NIA NIH HHS P30AG013854NIA NIH HHS P30 AG028377NIA NIH HHS P30AG028377NIA NIH HHS P30 AG028383NIA NIH HHS P30AG028383NIA NIH HHS P30AG08017NIA NIH HHS P30AG10161NIA NIH HHS P50 AG005133NIA NIH HHS P50AG005133NIA NIH HHS P50 AG005134NIA NIH HHS P50 AG005136NIA NIH HHS P50 AG005138NIA NIH HHS P50 AG005142NIA NIH HHS P50 AG005681NIA NIH HHS P50 AG008702NIA NIH HHS P50 AG016570NIA NIH HHS P50AG016570NIA NIH HHS P50 AG016574NIA NIH HHS P50AG016574NIA NIH HHS P50 AG016582NIA NIH HHS P50AG016582NIA NIH HHS P50AG05134NIA NIH HHS P50AG05136NIA NIH HHS P50AG05138NIA NIH HHS P50AG05142NIA NIH HHS P50AG05681NIA NIH HHS P50AG8702NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG027224NIA NIH HHS R01AG027224NIA NIH HHS R01 AG036040NIA NIH HHS R01 AG041797NIA NIH HHS R01AG17917NIA NIH HHS U01 AG032984NIA NIH HHS U24 AG021886NIA NIH HHS U24AG021886NIA NIH HHS U24 AG026395NIA NIH HHS U24 AG056270NIA NIH HHS U24AG26396
6 · The paper itself

Abstract

objectiveSeveral genome-wide association studies (GWAS) have associated variants in late-onset Alzheimer disease (LOAD) susceptibility genes; however, these single nucleotide polymorphisms (SNPs) have very modest effects, suggesting that single SNP approaches may be inadequate to identify genetic risks. An alternative approach is the use of multilocus genotype patterns (MLGPs) that combine SNPs at different susceptibility genes.

methodsUsing data from 1,365 subjects in the National Institute on Aging Late-Onset Alzheimer's Disease Family Study, we conducted a family-based association study in which we tabulated MLGPs for SNPs at CR1, BIN1, CLU, PICALM, and APOE. We used generalized estimating equations to model episodic memory as the dependent endophenotype of LOAD and the MLGPs as predictors while adjusting for sex, age, and education.

resultsSeveral genotype patterns influenced episodic memory performance. A pattern that included PICALM and CLU was the strongest genotypic profile for lower memory performance (β = -0.32, SE = 0.19, p = 0.021). The effect was stronger after addition of APOE (p = 0.016). Two additional patterns involving PICALM, CR1, and APOE and another pattern involving PICALM, BIN1, and APOE were also associated with significantly poorer memory performance (β = -0.44, SE = 0.09, p = 0.009 and β = -0.29, SE = 0.07, p = 0.012) even after exclusion of patients with LOAD. We also identified genotype pattern involving variants in PICALM, CLU, and APOE as a predictor of better memory performance (β = 0.26, SE = 0.10, p = 0.010).

conclusionsMLGPs provide an alternative analytical approach to predict an individual's genetic risk for episodic memory performance, a surrogate indicator of LOAD. Identifying genotypic patterns contributing to the decline of an individual's cognitive performance may be a critical step along the road to preclinical detection of Alzheimer disease.

Indexed as

Genetic Predisposition to DiseaseGenotypeMemory, EpisodicPolymorphism, Single NucleotideAdaptor Proteins, Signal TransducingAgedAged, 80 and overAlzheimer DiseaseApolipoproteins EClusterinFemaleGenome-Wide Association StudyHumansMaleMiddle AgedMonomeric Clathrin Assembly ProteinsAdaptor Proteins, Signal TransducingApolipoproteins EBIN1 protein, humanCLU protein, humanClusterinCR1 protein, humanMonomeric Clathrin Assembly ProteinsNuclear ProteinsPICALM protein, humanReceptors, Complement 3bTumor Suppressor Proteins

Identifiers

PMID22539578
PMCPMC3345618
OpenAlexW2085843402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.